Author

Yingying Hu

University of Helsinki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:non-human primate· 1 Approach:statistical model· 1

Frequent Co-Authors

Dara P. Dowlatshahi· 1 shared Hikaru SugimotoiD· 1 shared Hongbin YangiD· 1 shared Janine Hensel· 1 shared Jehad AldahdoohiD· 1 shared Jianli DaiiD· 1 shared Jing Ping TangiD· 1 shared Joe H. Simmons· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Dara P. Dowlatshahi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity

Xin Luo, Kathleen M. McAndrews, Kent A. Arian, Sami J. Morse, Viktoria Boeker, Shreyasee V. Kumbhar, Yingying Hu, Krishnan K. Mahadevan, Kaira A. Church, Sriram Chitta, Nicolas T. Ryujin, Janine Hensel, Jianli Dai, Dara P. Dowlatshahi, Hikaru Sugimoto, , Raghu Kalluri

This paper develops an engineered extracellular vesicles-based vaccine platform for combined mRNA and protein delivery, showing tumor regression and immune responses in preclinical models.

bioRxiv · Mar 14, 2024Immunology

DrugRepo: A novel approach to repurpose a huge collection of compounds based on chemical and genomic features

Yinyin Wang, Jehad Aldahdooh, Yingying Hu, Hongbin Yang, Markus J. V. Vähä-Koskela, Jing Ping Tang, Ziaurrehman Tanoli

This paper introduces a drug repurposing method using chemical and genomic data to score compounds for 674 cancer types and other diseases, with results matching ongoing clinical trials.

bioRxiv · Apr 21, 2022 · PreprintBioinformatics